Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. C. Kohn
Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2
Clinical Cancer Research
Cancer Research
Oncology
Tumor-Suppressor Function of Muscarinic Acetylcholine Receptors Is Associated With Activation of Receptor-Operated Calcium Influx.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary